Demand for GLP-1s grow, some payors balking at the costs; bariatric and metabolic surgery anticipated to grow - not shrink - along with rising GLP-1 adoption.

Demand for GLP-1s grow, some payors balking at the costs; bariatric and metabolic surgery anticipated to grow – not shrink – along with rising GLP-1 adoption.

Hello everyone, I hope you are quite well on this beautiful weekend (at least, here in the US Northeast). Virtually everyone I know, including yours truly and family, are out & about enjoying it. In this edition of our twenty30 newsletter, we continue to see keen media attention on GLP-1s, helping facilitate public fascination and concurrent […]

Demand for GLP-1s grow, some payors balking at the costs; bariatric and metabolic surgery anticipated to grow – not shrink – along with rising GLP-1 adoption. Read More »